IP Library Granted Patent US 7,306,949
Granted Patent B2
US 7,306,949 · App. 10/636,578 · Granted Dec 11, 2007

Combination of CRP and D-dimer for in vitro diagnosis of deep venous thrombosis (DVT)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,306,949
App. No.
10/636,578
Granted
Dec 11, 2007
Kind
B2
Abstract

The present invention relates to an in vitro diagnostic method for patients with suspected deep venous thrombosis wherein by combined testing of patients' samples for D-dimer and CRP both the sensitivity and the negative predictive value of DVT diagnostics can be increased up to 100%.

Claims (13)

1. A method for the diagnostic exclusion of the presence of deep venous thrombosis (DVT) in a patient at risk, comprising:

(a) testing of a liquid sample from said patient with a reagent for the detection of D-dimer;

(b) evaluating the test result:

(i) if the D-dimer concentration is found to be equal to or above a predefined cut-off value, DVT is not excluded with said patient;

(ii) if the D-dimer concentration is found to be below the said cut-off value, performing further testing according to (c):

(c) testing of a liquid sample from said patient with a reagent for the detection of C-reactive protein (CRP);

(d) evaluating the test result: if the CRP-concentration is found below a predefined cut-off value, DVT is excluded with said patient.

2. The method according to claim 1 , wherein the liquid sample is serum, plasma or whole blood.

3. The method according to claim 1 , wherein the reagents for the detection of D-dimer and for the detection of CRP are immunoassays.

4. The method according to claim 3 , wherein the reagents for the detection of D-dimer and for the detection of CRP independently of each other are based on test principles chosen from: ELISA, turbidimetry, nephelometry, particle enhanced turbidimetry, particle enhanced nephelometry, and latex agglutination.

5. The method according to claim 1 , wherein the predetermined cut-off value for D-dimer concentration is approximately 0.5 mg/I, and wherein the detection of D-dimer comprises a particle enhanced turbidimetric assay.

6. The method according to claim 1 , wherein the predetermined cut-off value for CRP concentration is approximately 4 mg/I, and wherein the detection of CRP comprises a particle enhanced nephelometric assay.

7. The method according to claim 1 , wherein the predetermined cut-off value for D-dimer concentration is approximately 0.5 mg/I, and wherein the detection of D-dimer comprises a particle enhanced turbidimetric assay, and further, wherein the predetermined cut-off value for CRP concentration is approximately 4 mg/I, and wherein the detection of CRP comprises a particle enhanced nephelometric assay.

Assignments (2)
CHANGE OF NAME Recorded Feb 26, 2009
From: DADE BEHRING MARBURG GMBH
To: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Reel/Frame 022309/0627 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2003
From: KORTE, WOLFGANG
To: DADE BEHRING MARBURG GMBH
Reel/Frame 014381/0776 →